With the advent of automatic cell imaging and machine learning, high-content phenotypic screening has become the approach of choice for drug discovery due to its ability to extract drug specific multilayered data and compare it to known profiles. In the field of epigenetics such screening approaches has suffered from the lack of tools sensitive to selective epigenetic perturbations. Here we describe a novel approach Microscopic Imaging of Epigenetic Landscapes (MIEL) that captures patterns of nuclear staining of epigenetic marks (e.g. acetylated and methylated histones) and employs machine learning to accurately distinguish between such patterns (1). We demonstrated that MIEL has superior resolution compared to conventional intensity thresholding techniques and enables efficient detection of epigenetically active compounds, function-based classification, flagging possible off-target effects and even predict novel drug function. We validated MIEL platform across multiple cells lines and using dose-response curves to insure the robustness of this approach for the high content high throughput drug discovery.
Improving drug discovery using image-based multiparametric analysis of epigenetic landscape
Chen Farhy,Luis Orozco,F. Zeng,I. Pass,J. Ylanko,S. Hariharan,Chun-Teng Huang,D. Andrews,A. Terskikh
Published 2019 in bioRxiv
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
bioRxiv
- Publication date
2019-02-05
- Fields of study
Biology, Medicine, Computer Science
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-92 of 92 references · Page 1 of 1
CITED BY
Showing 1-10 of 10 citing papers · Page 1 of 1